ANDREA COOPER: Open Payments
NPI 1093996134 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,142 in 46 payments from 13 companies in 2025. Trend: 2023 $831 · 2024 $1,249 · 2025 $1,142
Food & beverage: $1,141Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $228 |
| Novo Nordisk Inc | 7 | $157 |
| Ardelyx, Inc. | 5 | $138 |
| Calliditas Therapeutics US Inc. | 4 | $122 |
| Travere Therapeutics, Inc. | 4 | $105 |
| Vifor Pharma, Inc. | 4 | $92 |
| GENZYME CORPORATION | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $62 |
| AKEBIA THERAPEUTICS INC | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
Products named: IBSRELA, TARPEYO, Veltassa, Ozempic, Rybelsus, DUPIXENT, ACTHAR, Vafseo.
Industry payments across AR — which companies pay providers there.
